Kimera Labs is a biotech company focused on developing high-quality exosomes derived from mesenchymal stem cells, particularly from placental tissue. These exosomes are tiny, naturally occurring particles that play a role in cell communication and are being explored for use in regenerative medicine, skincare, and scientific research. The company follows strict manufacturing standards to ensure purity and safety, and it has received FDA approval to begin clinical trials on its exosome-based therapies. Kimera Labs is also a semifinalist in the prestigious XPRIZE Healthspan competition, highlighting its commitment to advancing longevity and health through cutting-edge science.